Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Salazar

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Gut|July 17, 2012
A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment predictionSun Tian, Iris Simon, Victor Moreno, et al.
Neuroendocrinology|January 21, 2012
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasmsMartyn Caplin, Anders Sundin, Ola Nillson, et al.
Investigational New Drugs|September 8, 2010
A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumorsEduardo Vilar, Viktor Grünwald, Patrick Schöffski, et al.
Oncotarget|September 17, 2016
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancerBernardo Queralt, Elisabet Cuyàs, Joaquim Bosch-Barrera, et al.
Journal of Endodontics|December 18, 2024
External Root Temperature and Its Relationship With Dentin Thickness During Gutta-Percha Removal Procedures With Ultrasound. An Ex Vivo StudyJuan Ramon Salazar-Silva, Carlos Emilio Paschoal, Daniela de Fatima Teixeira da Silva, et al.
Neuroendocrinology|August 29, 2009
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentationRudolf Arnold, Yuan-Jia Chen, Frederico Costa, et al.
Neuroendocrinology|January 21, 2012
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomasUlrich-Frank Pape, Aurel Perren, Bruno Niederle, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2014
Phase 1 dose escalation and pharmacokinetic evaluation of oral gemcitabine prodrug (LY2334737) in combination with docetaxel in patients with advanced solid tumorsRamon Salazar, Serafin Morales, Marta Gil-Martín, et al.
Neuroendocrinology|January 21, 2012
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasmsGianfranco Delle Fave, Dik J Kwekkeboom, Erik Van Cutsem, et al.
Neoplasia (New York, N.Y.)|October 27, 2011
Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell deathMireia Berdiel-Acer, Monika E Bohem, Adriana López-Doriga, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Gut|July 17, 2012
A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment predictionSun Tian, Iris Simon, Victor Moreno, et al.
Neuroendocrinology|January 21, 2012
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasmsMartyn Caplin, Anders Sundin, Ola Nillson, et al.
Investigational New Drugs|September 8, 2010
A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumorsEduardo Vilar, Viktor Grünwald, Patrick Schöffski, et al.
Oncotarget|September 17, 2016
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancerBernardo Queralt, Elisabet Cuyàs, Joaquim Bosch-Barrera, et al.
Journal of Endodontics|December 18, 2024
External Root Temperature and Its Relationship With Dentin Thickness During Gutta-Percha Removal Procedures With Ultrasound. An Ex Vivo StudyJuan Ramon Salazar-Silva, Carlos Emilio Paschoal, Daniela de Fatima Teixeira da Silva, et al.
Neuroendocrinology|August 29, 2009
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentationRudolf Arnold, Yuan-Jia Chen, Frederico Costa, et al.
Neuroendocrinology|January 21, 2012
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomasUlrich-Frank Pape, Aurel Perren, Bruno Niederle, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2014
Phase 1 dose escalation and pharmacokinetic evaluation of oral gemcitabine prodrug (LY2334737) in combination with docetaxel in patients with advanced solid tumorsRamon Salazar, Serafin Morales, Marta Gil-Martín, et al.
Neuroendocrinology|January 21, 2012
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasmsGianfranco Delle Fave, Dik J Kwekkeboom, Erik Van Cutsem, et al.
Neoplasia (New York, N.Y.)|October 27, 2011
Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell deathMireia Berdiel-Acer, Monika E Bohem, Adriana López-Doriga, et al.
Pageof 14